500 related articles for article (PubMed ID: 29795140)
1. The microbiome in prostate inflammation and prostate cancer.
Porter CM; Shrestha E; Peiffer LB; Sfanos KS
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):345-354. PubMed ID: 29795140
[TBL] [Abstract][Full Text] [Related]
2. Dying for love: Perimenopausal degeneration of vaginal microbiome drives the chronic inflammation-malignant transformation of benign prostatic hyperplasia to prostatic adenocarcinoma.
Reece AS
Med Hypotheses; 2017 Apr; 101():44-47. PubMed ID: 28351489
[TBL] [Abstract][Full Text] [Related]
3. [Chronic inflammation as promotor and treatment target in benign prostate hyperplasia (BPH) and in prostate cancer].
Kramer G; Mitteregger D; Maj-Hes A; Sevchenco S; Brozek W
Urologe A; 2007 Sep; 46(9):1095-6. PubMed ID: 17671777
[No Abstract] [Full Text] [Related]
4. The Microbiome and Prostate Cancer Risk.
Wheeler KM; Liss MA
Curr Urol Rep; 2019 Sep; 20(10):66. PubMed ID: 31493090
[TBL] [Abstract][Full Text] [Related]
5. The inflammatory microenvironment and microbiome in prostate cancer development.
Sfanos KS; Yegnasubramanian S; Nelson WG; De Marzo AM
Nat Rev Urol; 2018 Jan; 15(1):11-24. PubMed ID: 29089606
[TBL] [Abstract][Full Text] [Related]
6. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.
Shrestha E; White JR; Yu SH; Kulac I; Ertunc O; De Marzo AM; Yegnasubramanian S; Mangold LA; Partin AW; Sfanos KS
J Urol; 2018 Jan; 199(1):161-171. PubMed ID: 28797714
[TBL] [Abstract][Full Text] [Related]
7. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.
Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM
J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195
[TBL] [Abstract][Full Text] [Related]
8. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.
Kustrimovic N; Bombelli R; Baci D; Mortara L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675055
[TBL] [Abstract][Full Text] [Related]
9. The Correlation of Prostate Volume and Prostate-specific Antigen Levels With Positive Bacterial Prostate Tissue Cultures.
Heidler S; Drerup M; Lusuardi L; Bannert U; Bretterbauer K; Bures J; Dietersdorfer F; Dlouhy-Schütz E; Hessler C; Karpf R; Mittellehner LA; Mitlöhner B; Schwarz S; Thomay G; Lösch G; Freibauer C; Albrecht W
Urology; 2018 May; 115():151-156. PubMed ID: 29526510
[TBL] [Abstract][Full Text] [Related]
10. Human microbiome and prostate cancer development: current insights into the prevention and treatment.
Ohadian Moghadam S; Momeni SA
Front Med; 2021 Feb; 15(1):11-32. PubMed ID: 32607819
[TBL] [Abstract][Full Text] [Related]
11. Do men with prostate abnormalities (prostatitis/benign prostatic hyperplasia/prostate cancer) develop immunity to spermatozoa or seminal plasma?
Hoover P; Naz RK
Int J Androl; 2012 Aug; 35(4):608-15. PubMed ID: 22321000
[TBL] [Abstract][Full Text] [Related]
12. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
[TBL] [Abstract][Full Text] [Related]
13. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.
Dikov D; Bachurska S; Staikov D; Sarafian V
Prostate; 2015 Jul; 75(10):1074-84. PubMed ID: 25917232
[TBL] [Abstract][Full Text] [Related]
14. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
[TBL] [Abstract][Full Text] [Related]
15. The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.
Colinot DL; Garbuz T; Bosland MC; Wang L; Rice SE; Sullivan WJ; Arrizabalaga G; Jerde TJ
Prostate; 2017 Jul; 77(10):1066-1075. PubMed ID: 28497488
[TBL] [Abstract][Full Text] [Related]
16. [The microbiome in benign prostatic hyperplasia].
Magistro G; Füllhase C; Stief CG; Bschleipfer T
Urologe A; 2020 Oct; 59(10):1204-1207. PubMed ID: 32914231
[TBL] [Abstract][Full Text] [Related]
17. The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
Crocetto F; Boccellino M; Barone B; Di Zazzo E; Sciarra A; Galasso G; Settembre G; Quagliuolo L; Imbimbo C; Boffo S; Angelillo IF; Di Domenico M
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32878054
[TBL] [Abstract][Full Text] [Related]
18. [Bacterial content of the enucleated prostate gland].
Soler Soler JL; Hidalgo Domínguez MR; Zuluaga Gómez A; Martínez Torres JL; Lardelli Claret P; Liébana Ureña J; Saharour G
Arch Esp Urol; 1999 Oct; 52(8):823-34. PubMed ID: 10589113
[TBL] [Abstract][Full Text] [Related]
19. Implications of prostate inflammation on male fertility.
Motrich RD; Salazar FC; Breser ML; Mackern-Oberti JP; Godoy GJ; Olivera C; Paira DA; Rivero VE
Andrologia; 2018 Dec; 50(11):e13093. PubMed ID: 30569650
[TBL] [Abstract][Full Text] [Related]
20. The human microbiome links to prostate cancer risk and treatment (Review).
Xia B; Wang J; Zhang D; Hu X
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
